One promising ALKBH5 targeting agent is the imidazobenzoxazin-5-thione MV1035 that shows an ALKBH5 inhibition and repression of GBM cell lines (U87-MG cells) through downregulating CD73 expression (101). The gene discussed is ALKBH5; the disease is glioblastoma.